NS102
 | |
| Names | |
|---|---|
| IUPAC name
5-Nitro-6,7,8,9-tetrahydro-1H-benzo[g]indole-2,3-dione 3-oxime | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C12H11N3O4 | |
| Molar mass | 261.237 g·mol−1 |
| Appearance | Yellow solid |
| Insoluble | |
| Solubility in DMSO | >3 mg/mL |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
 verify (what is  ?) | |
| Infobox references | |
NS102 is a kainate receptor antagonist.[2][3]
References
- NS102 at Sigma-Aldrich
- Johansen, Tina H; Drejer, Joergen; Watjen, Frank; Nielsen, Elsebet O (1993). "A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding". European Journal of Pharmacology. 246 (3): 195–204. doi:10.1016/0922-4106(93)90031-4.
- Dev KK, Petersen V, Honoré T, Henley JM (1996). "Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain". J. Neurochem. 67 (6): 2609–12. doi:10.1046/j.1471-4159.1996.67062609.x. PMID 8931496.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.